SAN DIEGO, CA--(Marketwire - November 11, 2010) - Cytori Therapeutics (
Investigators from Cytori's APOLLO and PRECISE studies will review their clinical trial experience, the attributes of various sources for stem cells, and how, when and where cells should be delivered. In addition, they will each discuss future directions for the field, including trial design, endpoints, ways to further enhance the effects of the cells, and how such therapies will integrate with current standard-of-care. A Q&A session will be led and moderated by Jan Wald, PhD, of Noble Financial.
About Cytori
Cytori is a leader in providing patients and physicians around the world with medical technologies that harness the potential of adult regenerative cells from adipose tissue. The Celution® System family of medical devices and instruments is being sold into the European and Asian cosmetic and reconstructive surgery markets but is not yet available in the United States. Our StemSource® product line is sold globally for cell banking and research applications. www.cytori.com
Contact Information:
Contact:
Tom Baker
tbaker@cytori.com
858.875.5258